• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Aegon NV Pref Share

Aegon NV Pref Share

  1. UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of partial-onset seizures in epilepsy

    UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of partial-onset seizures in epilepsy

  2. UCB reinforces its leadership in epilepsy at the 2014 Annual Meeting of the American Epilepsy Society (AES)

    UCB reinforces its leadership in epilepsy at the 2014 Annual Meeting of the American Epilepsy Society (AES)

  3. G&Co and SPF Realty Partner for Dh2.8bn Millennium Square Project in Meydan City

    G&Co and SPF Realty Partner for Dh2.8bn Millennium Square Project in Meydan City

  4. Research and Markets: Cardiac Defibrillators - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea) Outlook 2018

    Research and Markets: Cardiac Defibrillators - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea) Outlook 2018

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.